0
Articles   |    
Thirty-Day Mortality After Total Knee Arthroplasty
Javad Parvizi, MD, FRCS; Thomas A. Sullivan, MD; Robert T. Trousdale, MD; David G. Lewallen, MD
View Disclosures and Other Information
Investigation performed at the Department of Orthopedics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Javad Parvizi, MD, FRCS
Thomas A. Sullivan, MD
Robert T. Trousdale, MD
David G. Lewallen, MD
Department of Orthopedics, Mayo Clinic and Mayo Foundation, 200 First Street S.W., Rochester, Minnesota 55905. E-mail address for R.T. Trousdale: trousdale.robert@mayo.edu

No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. No funds were received in support of this study.

The Journal of Bone & Joint Surgery.  2001; 83:1157-1161 
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Abstract

Background: There have been sporadic reports on perioperative mortality associated with total knee arthroplasty. The purpose of this study was to determine risk factors for such mortality.

Methods: A computer-assisted review of the records of 22,540 consecutive patients who had undergone total knee arthroplasty between 1969 and 1997 was performed to identify all patients who had died within thirty days after the procedure. A detailed analysis of the medical, surgical, anesthetic, and pathological records of the patients was performed, and the mortality was determined according to age, gender, diagnosis, and fixation method.

Results: The rate of mortality within thirty days after the operation was 0.21% (forty-seven of 22,540). All deaths occurred in the group of 18,810 patients who had received a cemented implant, and no deaths occurred among the 3730 patients who had received an uncemented implant (p < 0.0001). The mortality rate was 0.24% (forty-three of 18,165) after primary arthroplasty and 0.09% (four of 4375) after revision arthroplasty (p < 0.0003). Three patients (0.01%) died during the operation. Forty-three of the forty-seven patients who died had a history of preexisting cardiovascular and/or pulmonary disease. Simultaneous bilateral total knee arthroplasty was associated with a significantly higher rate of perioperative mortality (p < 0.002).

Conclusions: Factors that were associated with a significantly increased mortality after total knee arthroplasty included an age of more than seventy years, primary (as compared with revision) knee surgery, use of a cemented prosthesis, preexisting cardiopulmonary disease, and simultaneous bilateral arthroplasty.

Figures in this Article
    Total knee arthroplasty is a common orthopaedic procedure that is performed to treat arthritis that is unresponsive to nonoperative management. This procedure is considered generally safe, with a very low rate of perioperative death. However, because so many total knee arthroplasties are performed in the United States annually, a number of patients are likely to die after this procedure each year. Several authors have reported perioperative mortality rates associated with knee arthroplasty1-12, and several case reports have been published4,6,10,12. The exact cause of many of these deaths and the risk factors associated with mortality after total knee arthroplasty remain unclear. The purpose of this study was to report the rate of mortality within thirty days after total knee replacement in a large consecutive cohort of patients from a single institution. The patients were subdivided by age, gender, diagnosis, and fixation mode in an effort to identify the risk factors for such mortality.
     
    Anchor for JumpAnchor for JumpTABLE I:  Results of Univariate Analysis of Each Suspected Risk Factor for Perioperative Death within Thirty Days After Total Knee Arthroplasty
    Risk FactorTotalNo. of Patients Who Died (%)P Value
    Method of implant fixation
    With cement18,81047 (0.25)<0.0001
    Without cement3730?0 (0.00)
    Unilateral or bilateral procedure
    Unilateral19,86134 (0.17)<0.002
    Bilateral*267913 (0.49)
    Primary or revision procedure
    Primary18,16543 (0.24)<0.0003
    Revision4375?4 (0.09)
    Underlying diagnosis
    Osteoarthritis16,09132 (0.20)?0.82
    Rheumatoid arthritis610212 (0.20)
    Cardiorespiratory disease
    Yes871238 (0.44)<0.002
    No13,828?9 (0.07)
    Age (yr)
    >70722139 (0.54)<0.005
    <7015,319?8 (0.05)
    Gender
    Male982327 (0.27)?0.052
    Female12,71720 (0.16)
    *Bilateral procedures were performed during the same anesthetic session.
     
    Anchor for JumpAnchor for JumpTABLE II:  Prevalence of Cardiorespiratory Conditions Among Patients Who Died within Thirty Days After Total Knee Arthroplasty
    No. of Patients (%) (N = 47)
    History of cardiovascular and/or respiratory conditions43 (91.5)
    History of any cardiovascular conditions38 (80.9)
    Hypertension18 (38.3)
    Arrhythmia15 (31.9)
    Coronary artery disease?9 (19.1)
    Congestive cardiac failure?7 (14.9)
    Myocardial infarction?5 (10.6)
    Valvular disease?4 (8.5)
    History of respiratory conditions29 (61.7)
    Chronic obstructive pulmonary disease18 (38.3)
    Asthma11 (23.4)
    Restrictive lung disease?8 (17.0)
    Previous pulmonary embolism?5 (10.6)
    A computer-assisted review of 22,540 consecutive total knee arthroplasties that had been performed at our institution between 1969 and 1997 was conducted to identify patients who had died within thirty days after the operation. Data on all patients undergoing arthroplasty are entered prospectively into the Total Joint Registry at our institution, and the information is updated at regular intervals. We chose a thirty-day perioperative time-limit on the assumption that a shorter time-period might have led to the exclusion of deaths that were directly related to the knee surgery whereas a longer time-period might have led to the inclusion of deaths that were not attributable to the knee surgery.
    Forty-seven patients died within thirty days after total knee arthroplasty. The records of these forty-seven patients were reviewed with regard to age, gender, medical history, preoperative diagnosis, details of the operation (including whether or not cement was used), and postoperative events. The pathology department records were reviewed, and the findings at autopsy (if performed) were compared with the clinical cause of death that had been recorded prior to autopsy. The data on the forty-seven patients who died were compared with the data on all of the patients in the Total Joint Registry in order to calculate thirty-day mortality for the entire group as well as for specific subgroups that were stratified according to diagnosis, gender, type of operation (primary or revision, unilateral or bilateral), method of implant fixation (with or without cement), and age (more or less than seventy years).

    Statistical Analysis

    Single risk factors were analyzed with either the chi-square test or the Fisher exact test. Multivariate analysis was performed with use of a logistic regression model. Risk factors were retained in the model if they were either significant (p < 0.05) or of borderline significance (p < 0.10). During the modeling, two-way interactions were studied for all combinations of risk factors. After completion of the modeling, the relative risk of death for each combination of risk factors was estimated with 95% confidence intervals.

    Demographic Data

    Of the 22,540 patients who had a knee arthroplasty between 1969 and 1997, forty-seven died within thirty days after the operation. Twenty-seven of these patients were men, and twenty were women. The average age at the time of the procedure was significantly higher for those who died (seventy-five years; range, sixty to ninety years) than for those who did not die (65.5 years; range, sixteen to ninety-eight years) (p < 0.005). The average age of the patients who died after bilateral total knee arthroplasty (seventy-four years; range, seventy to eighty-eight years) was not significantly different from that of the patients who underwent unilateral total knee arthroplasty (seventy-five years; range, sixty to ninety years) (p = 0.7). The patients who underwent revision knee arthroplasty were younger than those who underwent primary knee arthroplasty (average age, 66.2 compared with 75.8 years) (p < 0.01). The average age of the 18,810 patients in whom the procedure was performed with cement (65.9 years; range, thirty-eight to ninety-six years) was significantly higher than that of the 3730 patients in whom the procedure was performed without cement (49.2 years; range, twenty-nine to sixty years) (p < 0.004).
    The indication for knee arthroplasty was osteoarthritis in thirty-two of the patients who died, rheumatoid arthritis in twelve, pathological fracture in one, ankylosing spondylitis in one, and avascular necrosis in one. Forty-three patients died after primary knee arthroplasty, and four died after revision arthroplasty. Thirteen (27.7%) of the forty-seven patients died after a one-stage bilateral knee arthroplasty performed during the same anesthetic session. Eight of the patients who died had had a previous knee arthroplasty on the contralateral side.

    Mortality Rates

    Three patients (0.01%) died intraoperatively. Two of these patients died after sudden cardiorespiratory collapse during cementing of the tibial component (one patient) or deflation of a tourniquet (one patient), and the third patient died during débridement of infected tissue and removal of a knee prosthesis. The overall thirty-day mortality after knee arthroplasty was 0.21% (forty-seven of 22,540), including the three intraoperative deaths. The thirty-day mortality after revision knee surgery (0.09%; four of 4375) was significantly lower than that after primary knee surgery (0.24%; forty-three of 18,165) (p < 0.0003). All four patients who died after revision surgery had received a long-stem, cemented prosthesis. There were no deaths among the 3730 patients in whom the procedure was performed without cement. The thirty-day mortality rate after procedures performed with cement (0.25%; forty-seven of 18,810) was significantly higher than that after procedures performed without cement (0%; zero of 3730) (p < 0.0001). Thirteen patients died after bilateral knee arthroplasty. Eleven of these thirteen patients had undergone a simultaneous bilateral knee arthroplasty, and the other two had undergone a staged bilateral knee arthroplasty during the same anesthetic session. The thirty-day mortality after bilateral knee arthroplasty (0.49%; thirteen of 2679) was significantly higher than that after unilateral knee arthroplasty (0.17%; thirty-four of 19,861) (p < 0.002). There was no difference in the mortality rates associated with different diagnoses. Specifically, the perioperative mortality among patients who had rheumatoid arthritis (0.20%; twelve of 6102) was not significantly different from that among patients who had osteoarthritis (0.20%; thirty-two of 16,091) (p = 0.82).

    Surgical Data

    Examination of the anesthetic records revealed that an intraoperative hypotensive event, defined as a drop in systolic blood pressure of more than 20 mm Hg, was observed in eighteen of the forty-seven patients who died. Hypotension occurred at the time of tourniquet deflation in seven patients, cementing of the tibial component in five, cementing of the femoral component in three, insertion of a femoral intramedullary guide-rod in two, and closure of the fascia in one. The hypotensive event was accompanied by a recorded arrhythmia in nine patients.

    Cause and Time of Death

    An autopsy was performed on thirteen of the forty-seven patients who died. Routine macroscopic pathological examination of vital organs was performed, and the site of the knee surgery was also examined in detail. The major findings were limited to the lungs and the heart. Comparison of the cause of death that had been recorded prior to autopsy with the actual cause of death that was identified at the time of the postmortem examination revealed a close association between the clinical and autopsy reports for eleven of thirteen patients. The cause of death was respiratory failure secondary to acute pulmonary edema in ten of the thirteen patients and acute myocardial infarction in three.
    No autopsy was performed for the other thirty-four patients who died; the presumed cause of death was sudden respiratory failure in twenty-one, cardiac arrest in eight, sepsis from a source other than the knee in two, and cerebrovascular accident in two. The remaining patient committed suicide twenty-seven days after the index procedure.
    Nineteen of the forty-seven patients died in the hospital.

    Medical History

    Forty-three of the forty-seven patients who died had a strong history of preexisting cardiovascular and/or pulmonary disease. Thirty-eight patients had a history of preexisting cardiovascular disease, and twenty-nine had a history of pulmonary disease (Table II). Twenty-three patients had coexistent cardiovascular and pulmonary disease, and twenty had at least two coexistent cardiovascular conditions.
    In 1983, our institution began routine recording of the American Society of Anesthesiologists score13 for all patients undergoing operative treatment. The average score was calculated for the patients who died, and we were able to obtain an accurate score for 7522 patients who did not die. The average score for the patients who died (3.2; range, 2 to 4) was significantly higher than that for the patients who did not die (2.4; range, 1 to 4) (p < 0.0001).

    Analysis of Risk Factors

    Univariate analysis revealed that several risk factors were associated with a significant increase in thirty-day mortality. These included use of a cemented prosthesis, one-stage simultaneous bilateral arthroplasty, an age of more than seventy years, primary arthroplasty, and a history of cardiorespiratory disease (Table I). Factors that were not significant included gender, operating surgeon, preoperative diagnosis (osteoarthritis or rheumatoid arthritis), and side of the operation.
    The present study provides data on perioperative mortality associated with total knee arthroplasty from a large consecutive cohort of patients who were operated on at a single institution. Primary arthroplasty was associated with significantly greater perioperative mortality compared with revision arthroplasty (p < 0.0003), despite the fact that revision procedures are longer and involve greater blood loss. The adverse effects of embolization of fat and marrow contents from a previously unviolated medullary canal may partly explain this difference. By using ultrasonography to detect emboli in the femoral vein and by analyzing femoral vein blood samples, Herndon et al.14 showed a markedly decreased amount of embolic material in patients who had had previous insertion of a cemented femoral hip prosthesis. However, selection bias may also have contributed to our results. For example, surgeons may have been more willing to subject older and less healthy patients to primary knee arthroplasty than to revision arthroplasty. In addition, the patients who underwent revision knee arthroplasty were younger than those who underwent primary knee arthroplasty (average age, 66.2 compared with 75.8 years; p < 0.01).
    An age of more than seventy years appeared to be a risk factor for perioperative mortality. Although we were unable to document the preoperative medical condition of the 22,493 patients who did not die after total knee surgery, it is reasonable to assume that older patients were more likely to have medical comorbidities that contributed to the risk of perioperative mortality.
    We also found that perioperative mortality after simultaneous bilateral total knee arthroplasty was significantly higher than that after unilateral arthroplasty (p < 0.002). The reasons for this finding are likely multiple and intertwined. The patients who died after bilateral arthroplasty were slightly sicker preoperatively than those who did not die after bilateral arthroplasty (average preoperative American Society of Anesthesiologists score, 2.6 compared with 2.3), but this difference was not significant (p = 0.7). Another possible explanation may be that simultaneous bilateral knee arthroplasty performed during the same anesthetic session may result in more blood loss, leading to a greater degree of hypotension and necessitating greater colloid and vasopressor administration. Finally, simultaneous bilateral knee arthroplasty may produce a higher "embolic load" of fat and marrow elements to the heart and lungs, with adverse physiological consequences leading to more pronounced cardiorespiratory disturbances in some patients. Lynch et al.5, in a study evaluating the risks associated with bilateral knee arthroplasty in elderly patients, observed that more cardiac, respiratory, and neurological complications developed in patients managed with bilateral arthroplasty than in those managed with unilateral arthroplasty.
    An interesting finding of this study was the higher mortality observed among patients who had cement fixation. This difference may have resulted in part from biased patient selection. Uncemented components were more often used for younger patients (average age, 49.2 years), during the years of peak use of these devices, whereas cemented components were more often used for elderly patients (average age, 65.9 years). In some patients, however, the difference may have been caused by the marrow fat and debris embolization process that has been shown to occur during total joint arthroplasty1,4,8,12,15-19. Orsini et al.20, in an experimental study in dogs, showed that increased intramedullary pressures were generated during cementation of femoral rods. Marked cardiorespiratory changes, including decreased arterial oxygen tension, increased intrapulmonary shunt fraction, and increased pulmonary arterial pressures, were observed. We believe that the rare intraoperative deaths reported previously8,16,21,22 and in the current study likely represent an uncommon fulminant manifestation of a very common physiologic insult associated with joint arthroplasty in an at-risk host. Frequently, patients undergoing knee replacement have concomitant cardiorespiratory diseases and may have limited cardiorespiratory reserve9,23. It has been postulated that such patients who have a cardiorespiratory crisis during cementation of components may go on to persistent pulmonary dysfunction, resulting in perioperative mortality9,20,23,24.
    Acute hypotension occurs commonly during cementing and has been associated with elevated pulmonary artery pressure and transient hypoxemia9,23,25-27. These physiological changes have been demonstrated at the time of cement and prosthesis insertion both in patients13,22,27 and in animals28. Although the pathophysiology of hypotension associated with implant insertion remains incompletely understood, release of particulate fat and marrow emboli has been clearly implicated24,28. The adverse effects of this embolic load can be moderated by decompression of the femoral canal by overdrilling the femoral entry hole, use of suction devices, use of fluted or cannulated rods, irrigation of the canal, and slow insertion of the instruments16,18,19.
    Another striking finding of this study was the presence of severe underlying cardiovascular and pulmonary disease in forty-three of the forty-seven patients who died. We were able to confirm that the prevalence of preexisting comorbidities, as measured by American Society of Anesthesiologists score, was significantly higher in patients who died compared with patients who did not die (p < 0.0001).
    In conclusion, the factors that were associated with increased mortality after knee arthroplasty included an age of more than seventy years, primary arthroplasty, the use of cement, preexisting cardiopulmonary disease, and simultaneous bilateral total knee arthroplasty. The overwhelming majority of the patients who died (forty-three of forty-seven) had preexisting cardiopulmonary disease. Recognizing these risk factors may enable the orthopaedic surgeon to reduce perioperative mortality after knee arthroplasty. Measures that may be worthy of consideration include avoiding bilateral one-stage total knee arthroplasty in patients who are ill or elderly; optimizing the medical condition of patients who have a history of cardiac or pulmonary problems; vigilant anesthetic monitoring, especially around the times of surgical measures that are known to be associated with marrow and fat embolization; and liberal use of vasopressor agents during episodes of hypotension. Modifications in surgical technique and implant choice to reduce marrow and fat embolization may also be appropriate in some high-risk patients. Awareness of the risk factors associated with perioperative mortality and use of measures to minimize the insult of the surgical procedure should help to make this already safe and effective operation even safer.
    Dorr LD, Merkel C, Mellman MF,Klein I. Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations. Clin Orthop,1989;248: 112-9. 248112  1989  [PubMed]
     
    Ivory JP, Simpson AH, Toogood GJ, McLardy-Smith PD,Goodfellow JW. Bilateral knee replacements: simultaneous or staged?. J R Coll Surg Edinb,1993;38: 105-7. 38105  1993  [PubMed]
     
    Jankiewicz JJ, Sculco TP, Ranawat CS, Behr C,Tarrentino S. One-stage versus 2-stage bilateral total knee arthroplasty. Clin Orthop,1994;309: 94-101. 30994  1994  [PubMed]
     
    Lachiewicz PF,Ranawat CS. Fat embolism syndrome following bilateral total knee replacement with total condylar prosthesis: report of two cases. Clin Orthop,1981;160: 106-8. 160106  1981  [PubMed]
     
    Lynch NM, Trousdale RT,Ilstrup DM. Complications after concomitant bilateral total knee arthroplasty in elderly patients. Mayo Clin Proc,1997;72: 799-805. 72799  1997  [PubMed]
     
    Monto RR, Garcia J,Callaghan JJ. Fatal fat embolism following total condylar knee arthroplasty. J Arthroplasty,1990;5: 291-5. 5291  1990  [PubMed]
     
    Morrey BF, Adams RA, Ilstrup DM,Bryan RS. Complications and mortality associated with bilateral or unilateral total knee arthroplasty. J Bone Joint Surg Am,1987;69: 484-8. 69484  1987  [PubMed]
     
    Orsini EC, Richards RR,Mullen JM. Fatal fat embolism during cemented total knee arthroplasty: a case report. Can J Surg,1986;29: 385-6. 29385  1986  [PubMed]
     
    Russin LA,Russin MA. Hip fracture: a review of 1,166 cases in a community hospital setting. Orthopedics,1981;4: 23-34. 423  1981 
     
    Stecker MS,Ries MD. Fatal pulmonary embolism during manipulation after total knee arthroplasty. A case report. J Bone Joint Surg Am,1996;78: 111-3. 78111  1996  [PubMed]
     
    Taylor HD, Dennis DA,Crane HS. Relationship between mortality rates and hospital patient volume for Medicare patients undergoing major orthopaedic surgery of the hip, knee, spine, and femur. J Arthroplasty,1997;12: 235-42. 12235  1997  [PubMed]
     
    Weiss SJ, Cheung AT, Stecker MM, Garino JP, Hughes JE,Murphy FL. Fatal paradoxical cerebral embolization during bilateral knee arthroplasty. Anesthesiology,1996;84: 721-3. 84721  1996  [PubMed]
     
    Tinker JH, Roberts SL. Anesthesia risk. In: Miller RD, editor. Anesthesia. 2nd ed. Volume 1. New York: Churchill Livingstone; 1986. p 365-6 
     
    Herndon JH, Bechtol CO,Crickenberger DP. Fat embolism during total hip arthroplasty. A prospective study. J Bone Joint Surg Am,1974;56: 1350-62. 561350  1974  [PubMed]
     
    Ereth MH, Weber JG, Abel MD, Lennon RL, Lewallen DG, Ilstrup DM,Rehder K. Cemented versus noncemented total hip arthroplasty—embolism, hemodynamics, and intrapulmonary shunting. Mayo Clin Proc,1992;67: 1066-74. 671066  1992  [PubMed]
     
    Fahmy NR, Chandler HP, Danylchuk K, Matta EB, Sunder N,Siliski JM. Blood-gas and circulatory changes during total knee replacement. Role of the intramedullary alignment rod. J Bone Joint Surg Am,1990;72: 19-26. 7219  1990  [PubMed]
     
    Parmet JL, Berman AT, Harrow JC, Harding S,Rosenberg H. Thromboembolism coincident with tourniquet deflation during total knee arthroplasty. Lancet,1993;341: 1057-8. 3411057  1993  [PubMed]
     
    Ries MD, Rauscher LA, Hoskins S, Lott D, Richman JA,Lynch F Jr. Intramedullary pressure and function during total knee arthroplasty. Clin Orthop,1998;356: 154-60. 356154  1998  [PubMed]
     
    Stern SH, Sharrock N, Kahn R,Insall JN. Hematologic and circulatory changes associated with total knee arthroplasty surgical instrumentation. Clin Orthop,1994;299: 179-89. 299179  1994  [PubMed]
     
    Orsini EC, Byrick RJ, Mullen JB, Kay JC,Waddell JP. Cardiopulmonary function and pulmonary microemboli during arthroplasty using cemented or non-cemented components. The role of intramedullary pressure. J Bone Joint Surg Am,1987;69: 822-32. 69822  1987  [PubMed]
     
    Patterson BM, Healey JH, Cornell CN,Sharrock NE. Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J Bone Joint Surg Am,1991;73: 271-7. 73271  1991  [PubMed]
     
    Parvizi J, Holiday AD, Ereth MH,Lewallen DG. Sudden death during hip arthroplasty. Clin Orthop,1999;369: 39-48. 36939  1999  [PubMed]
     
    Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P,Wilson PD. Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg,1995;80: 242-8. 80242  1995  [PubMed]
     
    Fabian TC. Unraveling the fat embolism syndrome. N Engl J Med,1993;329: 961-3. 329961  1993  [PubMed]
     
    Charnley J. Anchorage of the femoral head prosthesis to the shaft of the femur. J Bone Joint Surg Br,1960;42: 28-30. 4228  1960  [PubMed]
     
    McLaughlin TP,Fisher RL. Bilateral total knee arthroplasties. Comparison of simultaneous (two-team), sequential, and staged knee replacements. Clin Orthop,1985;199: 220-5. 199220  1985  [PubMed]
     
    Wheelwright EF, Byrick RJ, Wigglesworth DF, Kay JC, Wong PY, Mullen JB,Waddell JP. Hypotension during cemented arthroplasty. Relationship to cardiac output and fat embolism. J Bone Joint Surg Br,1993;75: 715-23. 75715  1993  [PubMed]
     
    Breed AL. Experimental production of vascular hypotensionand bone marrow and fat embolism with methylmethacrylate cement. Traumatic hypertension of bone. Clin Orthop,1974;102: 227-44. 102227  1974  [PubMed]
     

    Submit a comment

    Topics

    Anchor for JumpAnchor for JumpTABLE I:  Results of Univariate Analysis of Each Suspected Risk Factor for Perioperative Death within Thirty Days After Total Knee Arthroplasty
    Risk FactorTotalNo. of Patients Who Died (%)P Value
    Method of implant fixation
    With cement18,81047 (0.25)<0.0001
    Without cement3730?0 (0.00)
    Unilateral or bilateral procedure
    Unilateral19,86134 (0.17)<0.002
    Bilateral*267913 (0.49)
    Primary or revision procedure
    Primary18,16543 (0.24)<0.0003
    Revision4375?4 (0.09)
    Underlying diagnosis
    Osteoarthritis16,09132 (0.20)?0.82
    Rheumatoid arthritis610212 (0.20)
    Cardiorespiratory disease
    Yes871238 (0.44)<0.002
    No13,828?9 (0.07)
    Age (yr)
    >70722139 (0.54)<0.005
    <7015,319?8 (0.05)
    Gender
    Male982327 (0.27)?0.052
    Female12,71720 (0.16)
    *Bilateral procedures were performed during the same anesthetic session.
    Anchor for JumpAnchor for JumpTABLE II:  Prevalence of Cardiorespiratory Conditions Among Patients Who Died within Thirty Days After Total Knee Arthroplasty
    No. of Patients (%) (N = 47)
    History of cardiovascular and/or respiratory conditions43 (91.5)
    History of any cardiovascular conditions38 (80.9)
    Hypertension18 (38.3)
    Arrhythmia15 (31.9)
    Coronary artery disease?9 (19.1)
    Congestive cardiac failure?7 (14.9)
    Myocardial infarction?5 (10.6)
    Valvular disease?4 (8.5)
    History of respiratory conditions29 (61.7)
    Chronic obstructive pulmonary disease18 (38.3)
    Asthma11 (23.4)
    Restrictive lung disease?8 (17.0)
    Previous pulmonary embolism?5 (10.6)
    Dorr LD, Merkel C, Mellman MF,Klein I. Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations. Clin Orthop,1989;248: 112-9. 248112  1989  [PubMed]
     
    Ivory JP, Simpson AH, Toogood GJ, McLardy-Smith PD,Goodfellow JW. Bilateral knee replacements: simultaneous or staged?. J R Coll Surg Edinb,1993;38: 105-7. 38105  1993  [PubMed]
     
    Jankiewicz JJ, Sculco TP, Ranawat CS, Behr C,Tarrentino S. One-stage versus 2-stage bilateral total knee arthroplasty. Clin Orthop,1994;309: 94-101. 30994  1994  [PubMed]
     
    Lachiewicz PF,Ranawat CS. Fat embolism syndrome following bilateral total knee replacement with total condylar prosthesis: report of two cases. Clin Orthop,1981;160: 106-8. 160106  1981  [PubMed]
     
    Lynch NM, Trousdale RT,Ilstrup DM. Complications after concomitant bilateral total knee arthroplasty in elderly patients. Mayo Clin Proc,1997;72: 799-805. 72799  1997  [PubMed]
     
    Monto RR, Garcia J,Callaghan JJ. Fatal fat embolism following total condylar knee arthroplasty. J Arthroplasty,1990;5: 291-5. 5291  1990  [PubMed]
     
    Morrey BF, Adams RA, Ilstrup DM,Bryan RS. Complications and mortality associated with bilateral or unilateral total knee arthroplasty. J Bone Joint Surg Am,1987;69: 484-8. 69484  1987  [PubMed]
     
    Orsini EC, Richards RR,Mullen JM. Fatal fat embolism during cemented total knee arthroplasty: a case report. Can J Surg,1986;29: 385-6. 29385  1986  [PubMed]
     
    Russin LA,Russin MA. Hip fracture: a review of 1,166 cases in a community hospital setting. Orthopedics,1981;4: 23-34. 423  1981 
     
    Stecker MS,Ries MD. Fatal pulmonary embolism during manipulation after total knee arthroplasty. A case report. J Bone Joint Surg Am,1996;78: 111-3. 78111  1996  [PubMed]
     
    Taylor HD, Dennis DA,Crane HS. Relationship between mortality rates and hospital patient volume for Medicare patients undergoing major orthopaedic surgery of the hip, knee, spine, and femur. J Arthroplasty,1997;12: 235-42. 12235  1997  [PubMed]
     
    Weiss SJ, Cheung AT, Stecker MM, Garino JP, Hughes JE,Murphy FL. Fatal paradoxical cerebral embolization during bilateral knee arthroplasty. Anesthesiology,1996;84: 721-3. 84721  1996  [PubMed]
     
    Tinker JH, Roberts SL. Anesthesia risk. In: Miller RD, editor. Anesthesia. 2nd ed. Volume 1. New York: Churchill Livingstone; 1986. p 365-6 
     
    Herndon JH, Bechtol CO,Crickenberger DP. Fat embolism during total hip arthroplasty. A prospective study. J Bone Joint Surg Am,1974;56: 1350-62. 561350  1974  [PubMed]
     
    Ereth MH, Weber JG, Abel MD, Lennon RL, Lewallen DG, Ilstrup DM,Rehder K. Cemented versus noncemented total hip arthroplasty—embolism, hemodynamics, and intrapulmonary shunting. Mayo Clin Proc,1992;67: 1066-74. 671066  1992  [PubMed]
     
    Fahmy NR, Chandler HP, Danylchuk K, Matta EB, Sunder N,Siliski JM. Blood-gas and circulatory changes during total knee replacement. Role of the intramedullary alignment rod. J Bone Joint Surg Am,1990;72: 19-26. 7219  1990  [PubMed]
     
    Parmet JL, Berman AT, Harrow JC, Harding S,Rosenberg H. Thromboembolism coincident with tourniquet deflation during total knee arthroplasty. Lancet,1993;341: 1057-8. 3411057  1993  [PubMed]
     
    Ries MD, Rauscher LA, Hoskins S, Lott D, Richman JA,Lynch F Jr. Intramedullary pressure and function during total knee arthroplasty. Clin Orthop,1998;356: 154-60. 356154  1998  [PubMed]
     
    Stern SH, Sharrock N, Kahn R,Insall JN. Hematologic and circulatory changes associated with total knee arthroplasty surgical instrumentation. Clin Orthop,1994;299: 179-89. 299179  1994  [PubMed]
     
    Orsini EC, Byrick RJ, Mullen JB, Kay JC,Waddell JP. Cardiopulmonary function and pulmonary microemboli during arthroplasty using cemented or non-cemented components. The role of intramedullary pressure. J Bone Joint Surg Am,1987;69: 822-32. 69822  1987  [PubMed]
     
    Patterson BM, Healey JH, Cornell CN,Sharrock NE. Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J Bone Joint Surg Am,1991;73: 271-7. 73271  1991  [PubMed]
     
    Parvizi J, Holiday AD, Ereth MH,Lewallen DG. Sudden death during hip arthroplasty. Clin Orthop,1999;369: 39-48. 36939  1999  [PubMed]
     
    Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P,Wilson PD. Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg,1995;80: 242-8. 80242  1995  [PubMed]
     
    Fabian TC. Unraveling the fat embolism syndrome. N Engl J Med,1993;329: 961-3. 329961  1993  [PubMed]
     
    Charnley J. Anchorage of the femoral head prosthesis to the shaft of the femur. J Bone Joint Surg Br,1960;42: 28-30. 4228  1960  [PubMed]
     
    McLaughlin TP,Fisher RL. Bilateral total knee arthroplasties. Comparison of simultaneous (two-team), sequential, and staged knee replacements. Clin Orthop,1985;199: 220-5. 199220  1985  [PubMed]
     
    Wheelwright EF, Byrick RJ, Wigglesworth DF, Kay JC, Wong PY, Mullen JB,Waddell JP. Hypotension during cemented arthroplasty. Relationship to cardiac output and fat embolism. J Bone Joint Surg Br,1993;75: 715-23. 75715  1993  [PubMed]
     
    Breed AL. Experimental production of vascular hypotensionand bone marrow and fat embolism with methylmethacrylate cement. Traumatic hypertension of bone. Clin Orthop,1974;102: 227-44. 102227  1974  [PubMed]
     
    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe




    Related Articles
    Related Cases
    Related Content
    Topic Collections
    Related Audio and Videos
    PubMed Articles
    Guidelines
    Results provided by:
    PubMed
    Clinical Trials
    Readers of This Also Read...
    jbjs jobs
    12/22/2011
    VA - Charleston Area Medical Center
    12/22/2011
    ME - Central Maine Medical Center